Changing trend in the etiology of papilledema during the COVID-19 pandemic in India.
Ruhel Kurudamannil Chacko, Siddharth Narendran, Karthik Kumar, Virna M Shah
Author Information
- Ruhel Kurudamannil Chacko: Department of Neuro-Ophthalmology, Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Coimbatore, Tamil Nadu, India.
- Siddharth Narendran: Aravind Medical Research Foundation, Madurai and Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Coimbatore, Tamil Nadu, India.
- Karthik Kumar: Department of Neuro-Ophthalmology, Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Coimbatore, Tamil Nadu, India.
- Virna M Shah: Department of Neuro-Ophthalmology, Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Coimbatore, Tamil Nadu, India.
No abstract text available.
- Cerebrovasc Dis Extra. 2021;11(2):55-60
[PMID: 33975306]
- Crit Care Med. 2020 Sep;48(9):1358-1364
[PMID: 32467443]
- Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9
[PMID: 33010822]
- J Thromb Thrombolysis. 2020 Jul;50(1):54-67
[PMID: 32415579]
- Nature. 2021 Jul;595(7868):565-571
[PMID: 34153974]
- J Vasc Surg. 2020 Sep;72(3):799-804
[PMID: 32417304]
- Stroke. 2022 Sep;53(9):e407-e410
[PMID: 35920155]
- Diabetes Metab Syndr. 2021 May-Jun;15(3):1039-1045
[PMID: 34015627]
Humans
COVID-19
India
Papilledema
SARS-CoV-2
Pandemics
Incidence
